Terms: = Thyroid cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Treatment
17 results:
1. The application of autofluorescence system contributes to the preservation of parathyroid function during thyroid surgery.
Shi X; Lv G; Qin J; Li Y; Zheng L; Ding H; Sang J
Langenbecks Arch Surg; 2024 Mar; 409(1):96. PubMed ID: 38483607
[TBL] [Abstract] [Full Text] [Related]
2. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran.
Taziki M; Rajaei S; Firouzei G; Hashemzadeh F; Rajabalian M; Mansoury M; Sedaghat S; Ghahraman F; Ghasemi-Kebria F; Weiderpass E; Roshandel G
Cancer Epidemiol; 2022 Oct; 80():102247. PubMed ID: 36081275
[TBL] [Abstract] [Full Text] [Related]
3. Dexamethasone for Postoperative Nausea and Vomiting in Papillary thyroid Carcinoma Patients: A Randomized Clinical Trial.
Chen W; Li G; Jiang K; Song J; Du R; Yang H; Gou J; Li Z; Zhu J; Lei J
J Am Coll Surg; 2022 Sep; 235(3):454-467. PubMed ID: 35972165
[TBL] [Abstract] [Full Text] [Related]
4. A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.
Luo QW; Gao S; Lv X; Li SJ; Wang BF; Han QQ; Wang YP; Guan QL; Gong T
BMC Cancer; 2022 Jun; 22(1):606. PubMed ID: 35655253
[TBL] [Abstract] [Full Text] [Related]
5. First-line Gemcitabine
Yamamoto S; Narui K; Ishikawa T; Adachi S; Shimada K; Shimizu D; Yamada A; Sugae S; Tanabe M; Oba M; Morita S; Doi T; Hasegawa S; Morita T; Kito A; Chishima T; Ichikawa Y; Endo I;
Anticancer Res; 2021 Mar; 41(3):1671-1676. PubMed ID: 33788764
[TBL] [Abstract] [Full Text] [Related]
6. Effects of melatonin on the toxicity and proliferation of human anaplastic thyroid cancer cell line.
Ghorbani-Anarkooli M; Dabirian S; Zendedel A; Moladoust H; Bahadori MH
Acta Histochem; 2021 Apr; 123(3):151700. PubMed ID: 33667778
[TBL] [Abstract] [Full Text] [Related]
7. Blood prognostic predictors of treatment response for patients with papillary thyroid cancer.
Liu X; Huang Z; He X; Zheng X; Jia Q; Tan J; Fan Y; Lou C; Meng Z
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015713
[TBL] [Abstract] [Full Text] [Related]
8. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract] [Full Text] [Related]
9. The impact of surgery refusal on thyroid cancer survival: a SEER-based analysis.
van Gerwen M; Sinclair C; Rahman M; Genden E; Taioli E
Endocrine; 2020 Nov; 70(2):356-363. PubMed ID: 32307656
[TBL] [Abstract] [Full Text] [Related]
10. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y
Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247
[TBL] [Abstract] [Full Text] [Related]
11. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate thyroid Nodules.
Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
[TBL] [Abstract] [Full Text] [Related]
12. In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.
Rodriguez C; Carpano M; Curotto P; Thorp S; Casal M; Juvenal G; Pisarev M; Dagrosa MA
Radiat Environ Biophys; 2018 May; 57(2):143-152. PubMed ID: 29453554
[TBL] [Abstract] [Full Text] [Related]
13. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
Latteyer S; Tiedje V; König K; Ting S; Heukamp LC; Meder L; Schmid KW; Führer D; Moeller LC
Endocrine; 2016 Dec; 54(3):733-741. PubMed ID: 27696251
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Prognostic Score for Predicting Disease Remission with Differentiated thyroid cancers.
Somboonporn C; Mangklabruks A; Thakkinstian A; Vatanasapt P; Nakaphun S
Asian Pac J Cancer Prev; 2016; 17(6):2805-10. PubMed ID: 27356694
[TBL] [Abstract] [Full Text] [Related]
15. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
[TBL] [Abstract] [Full Text] [Related]
16. [Surgical management of medullary thyroid carcinoma. Personal experience].
Geraci G; Pisello F; Tornambè A; Platia L; Sciumè C; Li Volsi F; Cupido F; Modica G
G Chir; 2007 Oct; 28(10):385-9. PubMed ID: 17915054
[TBL] [Abstract] [Full Text] [Related]
17. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma.
Tubiana M; Schlumberger M; Rougier P; Laplanche A; Benhamou E; Gardet P; Caillou B; Travagli JP; Parmentier C
Cancer; 1985 Feb; 55(4):794-804. PubMed ID: 3967174
[TBL] [Abstract] [Full Text] [Related]
